OMRIX Biopharmaceuticals
11
0
0
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
55%
6 trials in Phase 3/4
22%
2 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
The Evicel Post-Authorization Surveillance Study
Role: collaborator
The Fibrin Patch Soft Tissue Study
Role: collaborator
A Clinical Study of Intravenous Immunoglobulin
Role: collaborator
The Fibrin Pad Liver Study
Role: collaborator
A Study to Evaluate the Safety and Effectiveness of EVICEL as an Adjunct to Sutured Dural Repair
Role: collaborator
Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery
Role: lead
Safety and Hemostatic Efficacy of Fibrin Fleece in Partial Nephrectomy
Role: lead
Evaluation of Fibrin Sealant 2 in Retroperitoneal or Intra-Abdominal Surgery
Role: collaborator
Pilot Study Evaluating the Safety and Potential Trends in Efficacy of Adhexil
Role: lead
A Study to Compare Human Thrombin Against Bovine Thrombin in Its Ability to Stop Bleeding After Surgery
Role: collaborator
Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures
Role: collaborator
All 11 trials loaded